These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10588173)

  • 1. Entry criteria for drug trials of irritable bowel syndrome.
    Kamm MA
    Am J Med; 1999 Nov; 107(5A):51S-58S. PubMed ID: 10588173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic therapy for the irritable bowel syndrome.
    Talley NJ
    Am J Gastroenterol; 2003 Apr; 98(4):750-8. PubMed ID: 12738451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritable bowel syndrome: update on pathogenesis and management.
    Alaradi O; Barkin JS
    Med Princ Pract; 2002; 11(1):2-17. PubMed ID: 12116690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tegaserod for the treatment of irritable bowel syndrome.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern.
    Simrén M; Abrahamsson H; Svedlund J; Björnsson ES
    Scand J Gastroenterol; 2001 May; 36(5):545-52. PubMed ID: 11346211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.
    Johnston JM; Shiff SJ; Quigley EM
    Curr Med Res Opin; 2013 Feb; 29(2):149-60. PubMed ID: 23198977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tegaserod: a review of its use in the management of irritable bowel syndrome with constipation in women.
    Wagstaff AJ; Frampton JE; Croom KF
    Drugs; 2003; 63(11):1101-20. PubMed ID: 12749744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irritable bowel syndrome: evaluation and treatment.
    Somers SC; Lembo A
    Gastroenterol Clin North Am; 2003 Jun; 32(2):507-29. PubMed ID: 12858604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation.
    Malagelada JR
    Int J Clin Pract; 2006 Jan; 60(1):57-63. PubMed ID: 16409429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic approach to the patient with irritable bowel syndrome.
    Camilleri M
    Am J Med; 1999 Nov; 107(5A):27S-32S. PubMed ID: 10588170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
    Raahave D
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials.
    Jailwala J; Imperiale TF; Kroenke K
    Ann Intern Med; 2000 Jul; 133(2):136-47. PubMed ID: 10896640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Episodic nature of symptoms in irritable bowel syndrome.
    Palsson OS; Baggish J; Whitehead WE
    Am J Gastroenterol; 2014 Sep; 109(9):1450-60. PubMed ID: 24980882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irritable bowel syndrome: a clinical review.
    Chey WD; Kurlander J; Eswaran S
    JAMA; 2015 Mar; 313(9):949-58. PubMed ID: 25734736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment of the irritable bowel syndrome.
    Pattee PL; Thompson WG
    Drugs; 1992 Aug; 44(2):200-6. PubMed ID: 1382014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome.
    Olden K; DeGarmo RG; Jhingran P; Bagby B; Decker C; Markowitz M; Carter E; Bobbitt W; Dahdul A; DeCastro E; Gringeri L; Johanson J; Levinson L; Mula G; Poleynard G; Stoltz RR; Truesdale R; Young D;
    Am J Gastroenterol; 2002 Dec; 97(12):3139-46. PubMed ID: 12492201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?
    Ford AC; Talley NJ; Veldhuyzen van Zanten SJ; Vakil NB; Simel DL; Moayyedi P
    JAMA; 2008 Oct; 300(15):1793-805. PubMed ID: 18854541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irritable bowel syndrome: new tools and insights for the primary care physician.
    Cleve Clin J Med; 2003 Jun; 70 Suppl 2():S8-20. PubMed ID: 12825863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.